How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
MEDPOT-PREDM
Effects of a Mediterranean Dietary Pattern With White Potato on Cardiometabolic Health in Adults With Pre-Diabetes
1 other identifier
interventional
60
1 country
2
Brief Summary
The goal of this clinical trial is to is to determine the effects of baked potato with the skin (BP) + nutrition education focused on adherence for a Mediterranean Dietary Pattern (MEDNE) on glycemic control, cardiometabolic health, and dietary quality in individuals with pre-diabetes from different demographic backgrounds. The main questions it aims to answer are:
- Does BP+MEDNE contribute to improvements in indices of glycemic control, vascular function, blood lipids, inflammation/oxidative stress, and body composition?
- Does BP+MEDNE contribute to improvements to overall dietary intake and quality? Researchers will compare BP+MEDNE to MEDNE alone to see if BP+MEDNE can improve glycemic control, cardiometabolic health, and dietary quality in individuals with pre-diabetes from different demographic backgrounds. Participants will:
- Be asked to come to the study site initially for a Screening Study Visit to confirm eligibility.
- Be asked to come the study site for a Pre-Baseline and Pre-12-Week Study Visit (one week prior to Baseline and 12-Week Study Visits) for placement of placement of a continuous glucose monitor and wearable devices to be removed at Baseline and 12-Week Study Visits.
- Be asked to come to the study site for Baseline, 6- and 12-Week Study Visits for assessments of glycemic control and cardiometabolic health.
- Be asked to complete 3-Day Food Records throughout the 12 week study period for assessment of dietary quality (5 total)
- Receive pre-recorded MEDNE ( which can be accessed via computer device/ipad/smartphone) after Baseline and 6-Week Study Visits.
- If randomized to the BP+MEDNE group, participants will receive pre-prepared baked potatoes with the skin for the 12-week study period (every 3 weeks) at Baseline and 6-Week Study Visits and asked to come to the study site for picking up the pre-prepared baked potatoes at weeks 3 and 9 of the study period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2025
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 24, 2025
CompletedFirst Posted
Study publicly available on registry
February 10, 2025
CompletedStudy Start
First participant enrolled
April 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
November 20, 2025
January 1, 2025
1.5 years
January 24, 2025
November 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in HemoglobinA1c
Fasting HemoglobinA1C percentage measured via Afinion AS100 Analyzer (point of care device)
Baseline and 12-Week Study Visits: 12 weeks
Change in Blood Glucose Levels
Fasting Blood Glucose Levels Measured with a Glucometer
Baseline, 6- and 12-Week Study Visits: 12 weeks
Change in Plasma Insulin Levels
Fasting Plasma Insulin Levels measured via ELISA
Baseline, 6- and 12-Week Study Visits: 12 weeks
Secondary Outcomes (26)
Change in blood pressure
Baseline, 6- and 12-Week Study Visits: 12 weeks
Changes in Arterial Stiffness-Pulse Wave Velocity
Baseline, 6- and 12-Week Study Visits: 12 weeks
Changes in Arterial Stiffness-Augmentation Index
Baseline, 6-Week, and 12-Week Study Visits: 12 Weeks
Changes in Lipid Profiles
Baseline, 6- and 12-Week Study Visits: 12 weeks
Change in Oxidized-LDL
Baseline, 6- and 12-Week Study Visits: 12 weeks
- +21 more secondary outcomes
Other Outcomes (2)
Changes in Glucose Time-in-Range and Peak Glucose
Pre-Baseline and Pre-12-Week Study Visits: 14 days, 7 prior to the Baseline and 12-Week Study Visits
Changes in Physical Activity and Sleeping Patterns via Wearable Device
Pre-Baseline and Pre-12-Week Study Visits: 14 days, 7 prior to the Baseline and 12-Week Study Visits
Study Arms (2)
Mediterranean Diet Nutrition Education
ACTIVE COMPARATORMediterranean Diet Nutrition Education with Baked White Potatoes
EXPERIMENTALInterventions
Participants randomized to receive the Mediterranean Diet Nutrition Education will receive a pre-recorded education session (lasting approximately 1 hour) they can watch at home after their Baseline and 6-Week Study Visits, which will be created by the PI and Co-I's of the study (who are comprised of Professors who are either Registered Dietitian credentialed or have experience with creating nutrition/physical activity programs), including an explanation of the principles and components of a Mediterranean dietary pattern and its benefits, guidance on recommended intake of various food groups, budget-friendly strategies for incorporation, supporting resources (educational materials and online tools), and techniques for overcoming barriers to following a Mediterranean dietary pattern. Additional educational materials will be provided to participants through computer or web-based sources.
Participants randomized to receive the Mediterranean Diet Nutrition Education with Baked White Potatoes will similarly receive a pre-recorded education session (lasting approximately 1 hour) they can watch at home after their Baseline and 6-Week Study Visits (same as the Mediterranean Diet Nutrition Education group). They will also receive will 100 g roasted white russet potatoes with the skin and will be asked to consume the regimen as a part of their meals (breakfast, lunch, dinner) or as a snack throughout the day to contribute to a balanced meal plan. The baked white potato regimen will be pre-portioned (in 100g amounts), stored in the freezer and given in freezer-microwave safe containers. The baked white potato regimen is approximately 100 kilocalories, 22g carbohydrates, and 0.2g of fat . In order to increase participants' compliance, they will be informed of a variety of ways to consume the baked white potato regimen.
Eligibility Criteria
You may qualify if:
- Men and postmenopausal women within the Las Vegas/Henderson NV area
- Ages 45-80 years
- BMI between 25-40 kg/m2
- HbA1c between 5.7-6.4%
- Individuals from different demographic backgrounds (i.e., American Indian or Alaska Native, Caucasians, Asian, Black or African-American, Native Hawaiian, Hispanic, Latino or Pacific Islander)
- Individuals who are considered "non-frequent" white potato consumers (\<2 servings of baked potatoes/week)
- Individuals from all races, genders, sexual identities, and religions will be included
- Individuals must follow certain guidelines, including avoiding new medications during the study or significant changes to lifestyle factors (e.g. beginning to smoke or exercise more or less than usual)
You may not qualify if:
- Individuals with uncontrolled hypertension (≥160/100mmHg), active cancer, asthma, thyroid, kidney, liver, or pancreatic diseases
- Individuals who are currently using insulin, on dialysis, changing/adding hypoglycemic, anti-hypertensive, and hypocholesterolemic medication within ≤3 months (or throughout the study)
- Individuals participating in weight loss programs or another clinical trial
- Individuals who start smoking
- Individuals who have unstable metabolic or chronic diseases
- Individuals who may have allergies to potatoes
- Woman who are currently pregnant, think they may be pregnant, or who is nursing cannot participate (women must be postmenopausal)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Department of Kinesiology and Nutrition Sciences
Las Vegas, Nevada, 89154, United States
University of Nevada Las Vegas
Las Vegas, Nevada, 89154, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Neda S Akhavan, PhD, RD
University of Nevada, Las Vegas
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 24, 2025
First Posted
February 10, 2025
Study Start
April 24, 2025
Primary Completion (Estimated)
October 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
November 20, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share
Individual Participant Data (IPD) will not be shared because the study did not obtain participant consent for data sharing, and there are concerns regarding the protection of participant privacy and confidentiality. Additionally, institutional and regulatory policies restrict data sharing, and the data are not intended for broader dissemination.